← Back to Patent Explorer
US4841968A Expired / Lapsed US ⏱️ 0.0 years remaining

Antithrombotic/thrombolytic suture and methods of making and using the same

Assignee: Southern Research Institute
•
Filing: 1986-09-26
•
Granted: 1989-06-27
•
Expires: 2006-09-26
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The controlled first-order release of either an antithrombotic or thrombolytic agent from a sutures at an anastomosis site is disclosed which prevents postoperative thrombosis and improves vascular patency in animals. A suitable polymer, such as polycaprolactone, is blended with prostacyclin or analogues of prostacyclin to form the suture material.

Inventors

  • 👤 Richard L. Dunn
  • 👤 John W. Gibson
  • 👤 Carlton A. Eddy
  • 👤 Leonard E. Laufe

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 16:43
CPC Classifications
A; A61; A61L; A61L17/00; A61L17/005; A61L2300/00; A61L2300/20; A61L2300/22; A61L2300/40; A61L2300/42; A61L2300/60; A61L2300/602

Claims Analysis

Total Claims: 8
Claim 1
Independent Claim 57 words
A surgical suture material for preventing postoperative thrombosis at an anastomosis site in animals, comprising a blend of a polymer and an effective amount of an antithrombotic or thrombolytic agent whereby said agent has a first-order rate of release from said suture material at said site and wherein said agent is prostacyclin or an analogue of prostacyclin.
Claim 2
Dependent Claim 57 words
A surgical suture material for preventing postoperative thrombosis at an anastomosis site in animals, comprising a blend of a polymer and an effective amount of an antithrombotic or thrombolytic agent whereby said agent has a first-order rate of release from said suture material at said site and wherein said agent is prostacyclin or an analogue of prostacyclin.
Claim 3
Dependent Claim 42 words
A surgical suture material for improving patency rates following arterial and venous microvascular anastomosis in animals, comprising extruded fibers of polycaprolactone and an effective amount of prostacyclin or an analogue of prostacyclin incorporated therein as a blend having first-order rate of release.
Claim 4
Dependent Claim 42 words
A surgical suture material for improving patency rates following arterial and venous microvascular anastomosis in animals, comprising extruded fibers of polycaprolactone and an effective amount of prostacyclin or an analogue of prostacyclin incorporated therein as a blend having first-order rate of release.
Claim 5
Independent Claim 57 words
A method of improving patency after anastomosis in animals, comprising the step of performing the anastomosis with surgical suture material formed of fibers of a polymer having an effective amount of an antithrombotic or thrombolytic agent incorporated therein as a blend having a first-order rate of release, wherein said agent is prostacyclin or an analogue of prostacyclin.
Claim 6
Independent Claim 57 words
A method of improving patency after anastomosis in animals, comprising the step of performing the anastomosis with surgical suture material formed of fibers of a polymer having an effective amount of an antithrombotic or thrombolytic agent incorporated therein as a blend having a first-order rate of release, wherein said agent is prostacyclin or an analogue of prostacyclin.
Claim 7
Independent Claim 51 words
A method of making surgical sutures, comprising the steps of: incorporating an effective amount of an antithrombotic or thrombolytic agent into a polymer to form a blend having first-order rate of release; and extruding said blend into a fibrous suture material, wherein said agent is prostacyclin or an analogue of prostacyclin.
Claim 8
Independent Claim 51 words
A method of making surgical sutures, comprising the steps of: incorporating an effective amount of an antithrombotic or thrombolytic agent into a polymer to form a blend having first-order rate of release; and extruding said blend into a fibrous suture material, wherein said agent is prostacyclin or an analogue of prostacyclin.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1992-06-26 1992-12-26 1993-06-27 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1996-06-26 1996-12-26 1997-06-27 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2000-06-26 2000-12-26 2001-06-27 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag